Caricamento...
A small molecule inhibits HCV replication and alters NS4B’s subcellular distribution
Hepatitis C Virus (HCV) is a leading cause of liver disease and represents a significant public health challenge. Treatments for this disease are inadequate and improved antiviral therapies are necessary. Several such antivirals are in development, most of which target the well-characterized NS3 pro...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3909674/ https://ncbi.nlm.nih.gov/pubmed/20363257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2010.03.013 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|